Insider Trading activities of Intercept Pharmaceuticals, Inc. (ICPT) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intercept Pharmaceuticals, Inc. (ICPT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intercept Pharmaceuticals, Inc. since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Intercept Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is ICPT. The reporting company's CIK number is 1270073.
The total value of stock buying since 2005 is $72,431,146.
The total value of stock sales since 2005 is $1,286,711,763.
The total value of stock option exercises since 2005 is $12,549,218.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Intercept Pharmaceuticals, Inc. insiders (ICPT) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-05-13 Akkaraju Srinivas Option Ex 1,500 21.50 32,250
2016-05-02 Mcminn Rachel (Chief Strategy Officer) Sale 130 147.49 19,173
2016-04-04 Bright Lisa (See Remarks) Sale 153 130.76 20,006
2016-04-04 Mcminn Rachel (Chief Strategy Officer) Sale 104 130.76 13,599
2016-04-04 Shapiro David (CMO and EVP - Development) Sale 165 130.76 21,575
2016-04-04 Pruzanski Mark (CEO & President) Sale 708 130.76 92,578
2016-04-04 Duncan Barbara Gayle (Chief Financial Officer) Sale 144 130.76 18,829
2016-02-25 Bright Lisa (See Remarks) Sale 241 115.22 27,768
2016-02-01 Mcminn Rachel (Chief Strategy Officer) Sale 128 103.56 13,255
2016-01-13 Bright Lisa (See Remarks) Sale 104 129.99 13,518
2016-01-12 Bright Lisa (See Remarks) Sale 624 124.78 77,862
2016-01-04 Mcminn Rachel (Chief Strategy Officer) Sale 469 145.90 68,428
2016-01-04 Shapiro David (CMO and EVP - Development) Sale 533 145.90 77,766
2016-01-04 Pruzanski Mark (CEO & President) Sale 2,126 145.90 310,191
2016-01-04 Duncan Barbara Gayle (Chief Financial Officer) Sale 468 145.90 68,283
2016-01-01 Shapiro David (CMO and EVP - Development) Option Ex 1,623 .00 0
2016-01-01 Pruzanski Mark (CEO & President) Option Ex 4,868 .00 0
2016-01-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 1,298 .00 0
2015-12-18 Shapiro David (CMO and EVP - Development) Option Ex 11,426 20.69 236,392
2015-12-15 Shapiro David (CMO and EVP - Development) Sale 3,500 157.41 550,952
2015-12-15 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-11-25 Bright Lisa (See Remarks) Sale 1,150 182.97 210,409
2015-11-20 Williams Nicole Sale 973 167.00 162,491
2015-11-20 Williams Nicole Option Ex 973 9.82 9,556
2015-11-16 Shapiro David (CMO and EVP - Development) Sale 4,264 178.75 762,177
2015-11-16 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-11-10 Shapiro David (CMO and EVP - Development) Sale 3,500 204.15 714,525
2015-11-10 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-11-10 Veitinger Klaus R Dr Sale 1,000 198.25 198,250
2015-11-10 Veitinger Klaus R Dr Option Ex 1,000 21.50 21,500
2015-11-02 Mcminn Rachel (Chief Strategy Officer) Sale 125 160.24 20,029
2015-10-28 Akkaraju Srinivas Option Ex 1,250 21.50 26,875
2015-10-20 Williams Nicole Sale 974 182.22 177,482
2015-10-20 Williams Nicole Option Ex 974 9.82 9,566
2015-10-02 Shapiro David (CMO and EVP - Development) Sale 858 159.04 136,455
2015-10-02 Pruzanski Mark (CEO & President) Sale 167 159.04 26,559
2015-10-02 Duncan Barbara Gayle (Chief Financial Officer) Sale 54 159.04 8,588
2015-10-01 Shapiro David (CMO and EVP - Development) Sale 282 163.39 46,075
2015-10-01 Shapiro David (CMO and EVP - Development) Option Ex 1,622 .00 0
2015-10-01 Pruzanski Mark (CEO & President) Option Ex 4,867 .00 0
2015-10-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2015-10-01 Duncan Barbara Gayle (Chief Financial Officer) Sale 1,000 163.39 163,390
2015-10-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 2,298 4.33 9,957
2015-09-21 Williams Nicole Sale 973 194.82 189,559
2015-09-21 Williams Nicole Option Ex 973 9.82 9,556
2015-09-15 Shapiro David (CMO and EVP - Development) Sale 3,500 191.02 668,563
2015-09-15 Shapiro David (CMO and EVP - Development) Option Ex 8,794 8.67 76,217
2015-09-09 Veitinger Klaus R Dr Sale 500 198.25 99,125
2015-09-09 Veitinger Klaus R Dr Option Ex 500 21.50 10,750
2015-08-20 Williams Nicole Sale 974 206.85 201,471
2015-08-20 Williams Nicole Option Ex 974 9.82 9,566
2015-08-17 Shapiro David (CMO and EVP - Development) Sale 4,272 209.37 894,428
2015-08-17 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-08-03 Veitinger Klaus R Dr Sale 500 261.17 130,585
2015-08-03 Veitinger Klaus R Dr Option Ex 500 21.50 10,750
2015-07-31 Mcminn Rachel (Chief Strategy Officer) Sale 127 262.09 33,285
2015-07-24 Fundaro Paolo Sale 582 285.00 165,870
2015-07-20 Williams Nicole Sale 973 279.01 271,476
2015-07-20 Williams Nicole Option Ex 973 9.82 9,556
2015-07-10 Pruzanski Mark (CEO & President) Sale 12,500 250.00 3,125,000
2015-07-10 Pruzanski Mark (CEO & President) Option Ex 12,500 8.67 108,337
2015-07-06 Adorini Luciano (Chief Scientific Officer) Sale 4,067 624.06 2,538,052
2015-07-06 Adorini Luciano (Chief Scientific Officer) Option Ex 4,067 15.08 61,342
2015-07-02 Shapiro David (CMO and EVP - Development) Sale 851 237.76 202,336
2015-07-02 Pruzanski Mark (CEO & President) Sale 158 237.76 37,566
2015-07-02 Duncan Barbara Gayle (Chief Financial Officer) Sale 53 237.76 12,601
2015-07-01 Shapiro David (CMO and EVP - Development) Sale 3,781 239.57 905,829
2015-07-01 Shapiro David (CMO and EVP - Development) Option Ex 5,123 4.33 30,334
2015-07-01 Pruzanski Mark (CEO & President) Option Ex 4,868 .00 0
2015-07-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2015-07-01 Duncan Barbara Gayle (Chief Financial Officer) Sale 1,000 242.10 242,100
2015-07-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 2,298 4.33 8,667
2015-06-22 Williams Nicole Sale 974 265.14 258,246
2015-06-22 Williams Nicole Option Ex 974 9.82 9,566
2015-06-15 Shapiro David (CMO and EVP - Development) Sale 3,500 241.54 845,393
2015-06-15 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-06-10 Veitinger Klaus R Dr Sale 391 238.21 93,140
2015-06-10 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2015-06-08 Adorini Luciano (Chief Scientific Officer) Sale 4,000 248.40 993,600
2015-06-08 Adorini Luciano (Chief Scientific Officer) Option Ex 4,000 8.67 34,668
2015-06-03 Pruzanski Mark (CEO & President) Option Ex 6,561 15.08 98,959
2015-05-20 Williams Nicole Sale 973 260.20 253,174
2015-05-20 Williams Nicole Option Ex 973 9.82 9,556
2015-05-19 Akkaraju Srinivas Option Ex 1,000 21.50 21,500
2015-05-15 Shapiro David (CMO and EVP - Development) Sale 4,279 306.95 1,313,447
2015-05-15 Shapiro David (CMO and EVP - Development) Option Ex 3,500 8.67 30,334
2015-05-14 Pruzanski Mark (CEO & President) Sale 5,000 300.00 1,500,000
2015-05-14 Pruzanski Mark (CEO & President) Option Ex 5,000 8.67 43,335
2015-05-11 Veitinger Klaus R Dr Sale 391 278.06 108,721
2015-05-11 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2015-05-06 Adorini Luciano (Chief Scientific Officer) Sale 4,000 260.54 1,042,167
2015-05-06 Adorini Luciano (Chief Scientific Officer) Option Ex 4,000 8.67 34,668
2015-05-01 Mcminn Rachel (Chief Strategy Officer) Sale 503 255.12 128,327
2015-05-01 Pruzanski Mark (CEO & President) Sale 12,500 255.23 3,190,350
2015-05-01 Pruzanski Mark (CEO & President) Option Ex 12,500 8.67 108,337
2015-04-20 Williams Nicole Sale 974 278.50 271,259
2015-04-20 Williams Nicole Option Ex 974 9.82 9,566
2015-04-10 Veitinger Klaus R Dr Sale 391 272.10 106,391
2015-04-10 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2015-04-06 Adorini Luciano (Chief Scientific Officer) Sale 4,000 268.98 1,075,908
2015-04-06 Adorini Luciano (Chief Scientific Officer) Option Ex 4,000 8.67 34,668
2015-04-02 Shapiro David (CMO and EVP - Development) Sale 843 277.70 234,101
2015-04-02 Pruzanski Mark (CEO & President) Sale 157 277.70 43,599
2015-04-02 Duncan Barbara Gayle (Chief Financial Officer) Sale 39 277.70 10,830
2015-04-01 Shapiro David (CMO and EVP - Development) Sale 2,616 274.56 718,235
2015-04-01 Shapiro David (CMO and EVP - Development) Option Ex 3,956 6.36 25,144
2015-04-01 Pruzanski Mark (CEO & President) Option Ex 4,868 .00 0
2015-04-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2015-04-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 1,298 .00 0
2015-03-27 Duncan Barbara Gayle (Chief Financial Officer) Sale 1,000 288.94 288,937
2015-03-26 Silverstein Jonathan Sale 157,200 287.71 45,228,797
2015-03-26 Isaly Samuel D Sale 157,200 287.71 45,228,797
2015-03-25 Silverstein Jonathan Sale 2,800 270.23 756,644
2015-03-25 Isaly Samuel D Sale 2,800 270.23 756,644
2015-03-24 Silverstein Jonathan Sale 45,600 271.80 12,394,034
2015-03-24 Isaly Samuel D Sale 45,600 271.80 12,394,034
2015-03-23 Silverstein Jonathan Sale 159,400 278.64 44,415,056
2015-03-23 Isaly Samuel D Sale 159,400 278.64 44,415,056
2015-03-20 Williams Nicole Sale 973 305.36 297,115
2015-03-20 Williams Nicole Option Ex 973 9.82 9,556
2015-03-16 Shapiro David (CMO and EVP - Development) Sale 3,500 285.88 1,000,573
2015-03-16 Shapiro David (CMO and EVP - Development) Option Ex 3,500 10.40 36,400
2015-03-12 Shapiro David (CMO and EVP - Development) Sale 5,000 285.99 1,429,940
2015-03-12 Shapiro David (CMO and EVP - Development) Option Ex 5,000 8.67 43,335
2015-03-10 Veitinger Klaus R Dr Sale 391 262.25 102,539
2015-03-10 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2015-02-24 Veitinger Klaus R Dr Sale 632 222.50 140,620
2015-02-24 Veitinger Klaus R Dr Option Ex 632 21.50 13,588
2015-02-20 Williams Nicole Sale 974 216.00 210,384
2015-02-20 Williams Nicole Option Ex 974 9.82 9,566
2015-02-17 Shapiro David (CMO and EVP - Development) Sale 4,646 209.23 972,082
2015-02-17 Shapiro David (CMO and EVP - Development) Option Ex 8,794 9.53 83,833
2015-02-10 Veitinger Klaus R Dr Sale 233 195.52 45,556
2015-02-10 Veitinger Klaus R Dr Option Ex 233 21.50 5,009
2015-01-30 Regan Daniel Paul (Chief Commercial Officer) Sale 9,847 203.60 2,004,878
2015-01-30 Regan Daniel Paul (Chief Commercial Officer) Option Ex 9,847 37.69 371,133
2015-01-30 Shapiro David (CMO and EVP - Development) Sale 7,500 206.33 1,547,490
2015-01-30 Shapiro David (CMO and EVP - Development) Option Ex 7,500 9.53 71,497
2015-01-20 Williams Nicole Sale 973 151.32 147,234
2015-01-20 Williams Nicole Option Ex 973 9.82 9,556
2015-01-12 Veitinger Klaus R Dr Sale 233 150.01 34,952
2015-01-12 Veitinger Klaus R Dr Option Ex 233 21.50 5,009
2015-01-05 Regan Daniel Paul (Chief Commercial Officer) Sale 146 176.49 25,766
2015-01-05 Shapiro David (CMO and EVP - Development) Sale 664 172.63 114,626
2015-01-05 Pruzanski Mark (CEO & President) Sale 461 176.49 81,360
2015-01-05 Duncan Barbara Gayle (Chief Financial Officer) Sale 141 176.49 24,884
2015-01-02 Shapiro David (CMO and EVP - Development) Sale 376 158.71 59,674
2015-01-02 Duncan Barbara Gayle (Chief Financial Officer) Sale 1,000 156.40 156,400
2015-01-02 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 1,000 31.90 31,900
2015-01-01 Shapiro David (CMO and EVP - Development) Option Ex 1,623 .00 0
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of ICPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intercept Pharmaceuticals, Inc. (symbol ICPT, CIK number 1270073) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month